Overview

A Study to Compare the Relative Bioavailability of Two 200 Mg Tramadol Hydrochloride Tablet Products Under Fasting Conditions

Status:
Completed

Trial end date:
2005-03-01

Target enrollment:

Participant gender:

Summary

To determine whether the test product, Labopharm Tramadol HCl Once-A-Day (OAD) 200 mg film-coated tablets, and the reference product, Labopharm Tramadol HCl OAD 200 mg uncoated tablets, are bioequivalent.

Phase:

Phase 1

Details

Lead Sponsor:

Labopharm Inc.

Treatments:

Tramadol